Phentolamine therapy for cocaine-association acute coronary syndrome (CAACS).

被引:16
作者
Chan G.M. [1 ]
Sharma R. [1 ]
Price D. [1 ]
Hoffman R.S. [1 ]
Nelson L.S. [1 ]
机构
[1] Department of Emergency Medicine, North Shore University Hospital, New York University School of Medicine, 300 Community Drive, Manhasset, 10030, NY
关键词
cocaine; acute coronary syndrome; phentolamine; toxicity;
D O I
10.1007/BF03161019
中图分类号
学科分类号
摘要
INTRODUCTION: The emergency department (ED) evaluation of cocaine-associated acute coronary syndrome (CAACS) is often a diagnostic and therapeutic challenge. CASE REPORT: We are reporting on the treatment of a patient with cocaine-associated acute coronary syndrome (CAACS) who did not benefit from standard therapy, but who eventually responded positively to phentolamine, an alpha-adrenergic receptor antagonist. DISCUSSION: This report should encourage physicians to add phentolamine to their pharmacotherapeutic armamentarium in the treatment of CAACS.
引用
收藏
页码:108 / 111
页数:3
相关论文
共 58 条
[1]  
Hollander JE(1995)The management of cocaine-associated myocardial ischemia N Engl J Med 333 1267-1272
[2]  
Brody SL(1990)Cocaine-related medical problems: Consecutive series of 233 patients Am J Med 88 325-331
[3]  
Slovis CM(1995)Cocaine-associated chest pain: one-year follow-up Acad Emerg Med 2 179-184
[4]  
Wrenn KD(1996)Cocaine-associated myocardial infarction J R Soc Med 89 443-447
[5]  
Hollander JE(2001)Cocaine use and acute myocardial infarction Emerg Med Clin North Am 19 493-510
[6]  
Hoffman RS(1981)Pneumomediastinum and pneumothorax after inhaling alkaloidal cocaine Ann Emerg Med 10 213-215
[7]  
Gennis P(1985)Pneumopericardium from cocaine inhalation N Engl J Med 313 48-49
[8]  
Fairweather P(1991)Pulmonary infarction associated with crack cocaine use in a previously healthy 23-year-old woman Am J Med 91 92-94
[9]  
Feldman JA(1993)Activation of human platelets by cocaine Circulation 88 876-883
[10]  
Fish SS(1990)Effect of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease: enhanced vasoconstriction at sites of significant stenoses J Am Coll Cardiol 16 74-79